Clinical Pharmacy
Share
26/04/2021
New DAPA-CKD Analysis Hints at Dapagliflozin for IgA Nephropathy The landmark DAPA-CKD trial showed that dapagliflozin slows CKD progression regardless of diabetes status. Now a prespecified analysis suggests it also works for CKD patients with an IgA etiology.
08/12/2020
20/06/2020
Want your practice to be the top-listed Clinic in Yerevan?
Click here to claim your Sponsored Listing.
Click here to claim your Sponsored Listing.
Category
Telephone
Website
Address
Yerevan
